JNJ
Johnson & JohnsonPharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #19
- Final score
- 72.40
- Years on list
- 6
↗ Climbed 98 since 2020
Compare · Up to four Russell 1000 companies
Put them side by side
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
- JNJ· Johnson & Johnson
- PFE· Pfizer Inc.
- ILMN· Illumina, Inc.
Figure 01 · Side-by-side summary
The headline numbers
PFE
Pfizer Inc.Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #33
- Final score
- 70.64
- Years on list
- 6
↗ Climbed 40 since 2020
ILMN
Illumina, Inc.Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #40
- Final score
- 69.66
- Years on list
- 6
↗ Climbed 490 since 2020
Figure 02 · Rank trajectory
Where each line is going
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2025
Where each one wins
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | JNJ | PFE | ILMN |
|---|---|---|---|
| Climate Change | 70.5 | 80.7 | 92.8 |
| Employee Relations | 79.9 | 62.5 | 57.2 |
| Environment | 71.1 | 75.1 | 69.9 |
| Stakeholders & Society | 74.4 | 73.5 | 77.7 |
| Human Rights | 64.3 | 58.9 | 55.7 |
| Governance | 69.2 | 63.1 | 51.7 |
| Performance Rating | 73.2 | 74.2 | 57.3 |